The Center for Clinical Epidemiology and Biostatistics (CCEB) and the Abramson Cancer Center (ACC), an NCI-designated Comprehensive Cancer Center, in collaboration with the Division of Hematology-Oncology of the Department of Medicine and the Division of Oncology of the Department of Pediatrics, all at the University of Pennsylvania (Penn) Perelman School of Medicine (PSOM), propose to continue an innovative, rigorous, and successful two- to three-year training program for investigators in cancer clinical epidemiology. This training program attracts cancer clinical epidemiology trainees from across the country; its graduates are placed in institutions nationwide, resulting in a program of high impact.The program will: 1) train primarily physicians to be rigorous, independent academic investigators able to use a wide range of epidemiological methods to address clinical cancer research questions using a variety of designs; 2) provide closely mentored research experiences with faculty preceptors in clinical epidemiology, biostatistics, and cancer; and 3) strengthen the links between traditional epidemiology and cancer research. Didactic training is provided under auspices of the Master of Science in Clinical Epidemiology (MSCE) program which provides regular feedback to the directors of the training program (CCETP) to maximize the progress of each fellow. The training program is focused on the completion of a rigorous mentored research thesis project. The thesis is based on the long term research interests of the fellow, carefully designed in a grant proposal format, executed, analysed, and written up as first author manuscript(s). The principal concepts necessary for rigorous research are taught in courses of fundamental epidemiological methods, cancer and molecular epidemiology, and biostatistics, elective courses relevant to the trainees' methodologic interests; journal clubs and clinical research conferences conducted by participating faculty, the CCEB, ACC, and adult and pediatric oncology divisions; extensive independent readings; and instruction in the responsible conduct of research. Strengths of the proposed program are: 1) the long history of successful research training programs in the CCEB, ACC, and adult and pediatric oncology divisions, including this training program; 2) the collaborative links that have been forged among faculty with interests in clinical research in cancer; 3) the comprehensive course offerings and research programs that are available to trainees; and 4) an extensive set of experienced and multidisciplinary faculty with successful training records. In addition, numerous existing large databases that can be used for research projects and training; a broad array of specialized analytic capabilities available for clinical studies employing methods of clinical epidemiology (e.g., clinical trials, case-control, cohort research, etc.); and commitment of faculty to collaborative research and training, combine to provide an ideal environment for this training program. Finally, the PSOM promote an academic environment in which basic and clinical research are encouraged and viewed as attractive career paths for physicians.

Public Health Relevance

There is a major national shortage of qualified clinician-scientists able to conduct the rigorous clinical research needed to optimize cancer treatment and prevention. This training program addresses this shortage through the efforts of a distinguished, experienced, and committed training program faculty. Training will continue to be provided to those who desire careers as clinician-scientists focusing on cancer clinical research through a program that provides trainees with the skills needed to develop and successfully implement highly successful cancer epidemiology studies that will address the most vexing population-based questions in cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009679-27
Application #
9522154
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Lim, Susan E
Project Start
1992-09-01
Project End
2022-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
27
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Family Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
McAndrew, Nicholas; DeMichele, Angela (2018) Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer. J Target Ther Cancer 7:52-69
DiNofia, Amanda M; Seif, Alix E; Devidas, Meenakshi et al. (2018) Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232. Cancer Med 7:3-12
Wertheim, Gerald B W; Luskin, Marlise R; Carroll, Martin et al. (2017) Microsphere-Based Assessment of DNA Methylation for AML Prognosis. Methods Mol Biol 1633:125-136
Munzone, Elisabetta; Colleoni, Marco (2017) Metronomics in the neoadjuvant and adjuvant treatment of breast cancer. Cancer Lett 400:259-266
Brickman, Cristina; Propert, Kathleen J; Voytek, Chelsea et al. (2017) Association Between Depression and Condom Use Differs by Sexual Behavior Group in Patients with HIV. AIDS Behav 21:1676-1683
Corwin, Daniel J; Grady, Matthew F; Joffe, Mark D et al. (2017) Pediatric Mild Traumatic Brain Injury in the Acute Setting. Pediatr Emerg Care 33:643-649
DiNofia, Amanda M; Salazar, Elizabeth; Seif, Alix E et al. (2016) Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States. PLoS One 11:e0151362
Luskin, Marlise R; Gimotty, Phyllis A; Smith, Catherine et al. (2016) A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia. JCI Insight 1:
Kumar, Anita J; Gimotty, Phyllis A; Gelfand, Joel M et al. (2016) Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII. Am J Hematol 91:1107-1112
Luskin, Marlise R; Carroll, Martin; Lieberman, David et al. (2016) Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant 22:1961-1967

Showing the most recent 10 out of 34 publications